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Abstract In a previous experiment, it was shown that midkine 
(MK) was quite abundant in the follicular fluid; the concentration 
of MK in bovine follicular fluid was estimated to be 125 ~tg/I. To 
investigate the regulation of MK production in the ovary, we 
examined the effect of pregnant mare's serum gonadotropin 
(PMSG) and PMSG-hCG treatment on the expression of MK 
in rat ovary. The mRNA of midkine (MK) was increased by 
PMSG injection and decreased by PMSG and hCG injection; the 
profile of change of mRNA of MK was similar to that of FSH 
receptor. Using in situ hybridization, we observed that the MK 
mRNA localized to granulosa cells. These results suggest hat the 
granulosa cells produce MK under the control of gonadotropin. 
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1. Introduction 
Midkine (MK) is the product of a retinoic acid responsive 
gene, MK, and constitutes a new family of heparin-binding 
growth/differentiation factors together with heparin-binding 
growth-associated molecule (HB-GAM)/pleiotrophin (PTN) 
[1-7]. MK is transiently expressed in the early stages of embry- 
onal carcinoma cell differentiation and in the mid-gestation 
period of mouse embryogenesis [1,8,9]. In adult mouse it is 
significantly expressed only in the kidney and uterus [8,9], but 
it is widely expressed in adult rat and human tissues [10,11]. It 
has been reported that MK promotes neurite extension [10,12 
14], enhances neuronal survival [4,15-17], and is related to 
human carcinoma [11,18]. Recently MK was isolated from bo- 
vine follicular fluid by using an assay which detects the growth 
promoting activity on bovine aortic smooth muscle cells. The 
concentration of MK in bovine follicular fluid was estimated 
to be 125 ng/ml and this concentration was comparable to those 
of activin and inhibin [19]. These findings suggest hat MK may 
play a role in the maturation of ovarian follicles. Since the 
gonadotropic hormones have important regulatory roles in fol- 
liculogenesis, we have examined expression of MK mRNA in 
the ovary of immature rats treated with gonadotropines using 
both quantitative assays to measure MK mRNA abundance as 
well as in situ hybridization to examine the cellular distribution 
of this transcript. 
2. Materials and methods 
2.1. Animals" 
Immature female rats of the Wistar strain were primed with 30 IU 
of pregnant mare's erum gonadotropin (PMSG) alone or 30 IU PMSG 
and 20 IU of hCG 60 h later. Animals were sacrificed at selected 
intervals following hormone treatment. The rats were killed and their 
ovaries were removed, frozen immediately in liquid nitrogen, and stored 
until use at -80°C . 
2.2. Synthesis of the RNA probe 
Human MK cDNA was subcloned into the BamHI and EcoRI site 
of the Bluescript KS(+) vector. Digoxigenin-labeled sense or antisense 
riboprobe RNA were produced from EcoRI- or BamHI-digested plas- 
mid DNA by in vitro transcription with T7 or T3 RNA polymerase, 
respectively, with an RNA labeling kit (Boeringer-Mannheim). 
2.3. Extraction of RNA and Northern blot analysis 
Total RNA was extracted from the ovaries by the acid guanidinium 
thiocyanate/phenol/chloroform extraction method. The final RNA pel- 
let was dissolved in diethyl pyrocarbonate treated H20. Total RNA was 
quantified by measuring the absorbance of samples at 260 nm. For 
Northern blot analysis, 10pg total RNA was separated by electropho- 
resis on 1% agarose gels and subsequently transferred to a nylon mem- 
brane (Biodyne; ICN) [20,21]. Northern blots were hybridized at 68°C 
with digoxigenin-labeled antisense riboprobe RNA. Following the 
standard protocol for the nucleic acid detection kit (Boehringer- 
Mannheim), membranes were then exposed to Kodak X-Omat film 
(Eastman Kodak, Rochester, NY). The relative abundance of a 1000 
base signal in different preparations was analyzed with an LKB 2202 
UnitroScan Laser Densitometer (LKB Produker AB, Bromma, Swe- 
den) and standardized against he corresponding amount of fl-actin 
mRNA. 
2.4. In situ hybridization 
Rat ovaries were embedded into tissue compound and frozen in 
liquid nitrogen. 7¢tm thick sections were cut by a cryostat and mounted 
on silane-coated glass slides for in situ hybridization. The tissue sections 
were fixed in 4% paraformaldehyde in PBS and then hybridized with 
digoxigenin-labeled riboprobe in the hybridization buffer (1 mg/ml 
yeast RNA, 20 mM Tris-HCl, pH 8.0, 2.5 mM EDTA, pH 8.0, 1 x 
Denhardt's olution, 0.3 M NaC1, 50% deionized formamide, 10% 
dextran sulfate) for 16 h at 50°C. Hybridized sections were then washed 
with 2 x SSC/50% formamide and I x SSC/50% formamide after treat- 
ment with RNase A (20 pg/ml in 10 mM Tris-HCl, pH 7.6, 500 mM 
NaC1, 1 mM EDTA) for 30 min at 37°C. The hybridization material 
was reacted with alkaline phosphatase-conjugated nti-digoxigenin a - 
tibody and then detected by color reaction in the incubation medium 
containing Nitroblue tetrazolium, 5-bromo-4-chloro-3-indolyl- 
phosphate and levamisole, an inhibitor of endogenous alkaline phos- 
phatase, according to the manufacturer's manual (Digoxigenin De- 
tection kit; Boeringer-Mannheim) [22]. 
3. Results and discussion 
*Corresponding author. Fax: (81) (272) 20-8443. 
One extremely informative model for studying follicular de- 
velopment has been the hormonally primed immature animal, 
in which small follicles can be induced to develop in response 
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3. In the previous experiments, the PMSG treatment increased 
mRNA levels of both FSH and LH/hCG receptor followed by 
an increase of receptor numbers in the membrane. The mRNA 
level of FSH receptor increased earlier than that of LH/hCG 
receptor and slightly decreased by day 4 of the experiment [23]. 
Taken together, the transcript of MK was induced by PMSG 
treatment which increased the FSH receptor and stimulated 
follicular growth. In the same experiment, the PMSG-hCG 
treatment caused a decrease in FSH receptor mRNA levels and 
suppressed the LH/hCG receptor mRNA 12-24h after injec- 
tion; the levels increased to control levels by 48 h and this was 
followed by a progressive increase [23,24]. Therefore, we tried 
to investigate the changes of MK mRNA following the admin- 
istration of hCG to PMSG-primed immature rats. As shown 
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Fig. 1. The effect of PMSG treatment on midkine and fl-actin mRNA 
levels in immature female rat ovary. From each time point 10pg of total 
RNA was prepared and fractionated through a 1% agarose gel and 
blotted as described in section 2. (A) Blots were probed with digoxi- 
genin-labeled midkine cRNA (above) or fl-actin cRNA (below). Mem- 
branes were exposed to Kodak X-Omat film. (B) Autoradiographs were 
quantitated by densitometric scanning and the change of midkine 
mRNA (1000 band) relative to fl-actin is expressed as arbitrary units. 
The mRNA level at each time point is expressed as the fold increase 
over day 0. The results represent the mean + S.E.M. of three experi- 
ments. *Different from the value of day 0 at P<0.01. 
to PMSG and to luteinize in response to an ovulatory dose of 
hCG. Therefore, to determine whether the gonadotropins 
could modulate levels of MK mRNA,  we treated immature rats 
with PMSG to stimulate follicular development or with PMSG 
followed by an ovulatory dose of hCG. As shown in Fig. 1, 
Northern blot analysis of MK revealed a major RNA of 1000 
nucleotides, and this transcript was present in the control 
ovary, reached a peak on day 2, and slightly decreased at day 
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Fig. 2. The effect of PMSG and hCG treatment on midkine and fl-actin 
mRNA levels in immature rat ovary. (A) Midkine mRNA (above), 
fl-actin mRNA (below). (B) Autoradiographs were quantitated by den- 
sitometric scanning and the change in midkine mRNA (1000 band) 
relative to fl-actin is expressed as arbitrary units. The mRNA level at 
each time point is expressed as the fold increase over day 3. The results 
represent the mean _+ S.E.M. of three experiments. *Different from the 
value of day 3 at P<0.01. 
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Fig. 3. In situ hybridization of the ovary 2 days after hCG treatment 
with a digoxigenin-labeled riboprobe for midkine. The tissue sections 
were fixed with 4% paraformaldehyde in PBS and then hybridized with 
digoxigenin-labeled antisense (A,B) and sense (C) RNA probes in the 
hybridization buffer. Hybridized sections were then washed as de- 
scribed in section 2. A specific hybridization signal is seen in the gran- 
ulosa cells of the follicles (A), especially inthe cytoplasm of granulosa 
cells (B), while it is absent in C. 
in Fig. 2, Northern blot analysis revealed that hCG injection 
decreased mRNA of MK. These data showed that the mRNA 
level of MK was suppressed by hCG injection which stimulated 
ovulation and luteinization of the ovary. Using both systems, 
we found that PMSG increased MK mRNA levels and that 
subsequent administration f hCG to PMSG-primed animals 
caused adecline in MK mRNA levels to basal values. Although 
the profile of change of MK mRNA was the same as that of 
FSH receptor and LH receptor mRNA before hCG injection, 
after the hCG injection the profile was rather similar to that of 
FSH receptor mRNA. 
Fig. 3 shows in situ hybridizations performed using adjacent 
ovarian sections from the hormonally treated rats. The MK 
mRNA was located exclusively to the granulosa cells of healthy 
follicles. No specific hybridization was observed when sense 
strand MK RNA probes were used. The timemourse ofexpres- 
sion of MK responding to the gonadotropins and localization 
of MK are comparable to those of FSH receptor, which is 
expressed in mature follicles. Moreover, this suggests that some 
common regulatory mechanisms for FSH receptor and MK 
mRNA might be operative in the case of these genes. On the 
other hand, these results how that the granulosa cells produce 
MK at least partially under the control of gonadotropin. MK 
are known to constitute a new family of heparin-binding 
growth/differentiation factors, which is distinct from the fi- 
broblast growth factor (FGF) family. The present findings 
show that MK is expressed ingranulosa cells and its production 
may be regulated by gonadotropins: these results do not con- 
flict with the presence of high concentrations of MK in follicu- 
lar fluid. In a previous tudy, it was shown that MK was quite 
abundant in the follicular fluid; the concentration f MK in 
bovine follicular fluid was estimated to be 125/.tg/1. More than 
50 ng/ml of MK exerted agrowth promoting activity on bovine 
aortic smooth muscle cells [19]. Although the previous tudies 
suggested that MK might play a role in fetal development, bone 
formation and brain function [6,14,25], the precise function of 
this factor remains unknown. To elucidate whether MK exert 
the growth promoting activity on the granulosa cells will re- 
quire further experiments. 
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